Malin Life Sciences Holdings Ltd - 08 Aug 2022 Form 4 Insider Report for Poseida Therapeutics, Inc.

Role
10%+ Owner
Signature
By: /s/ Fiona Dunlevy, Company Secretary
Issuer symbol
N/A
Transactions as of
08 Aug 2022
Net transactions value
+$7,525,000
Form type
4
Filing time
10 Aug 2022, 20:49:36 UTC
Previous filing
07 Dec 2021
Next filing
10 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX COMMON STOCK Purchase $7,525,000 +2,150,000 +22% $3.50 11,835,673 08 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Table I, 2A: Subscribed through the prospectus supplement dated August 3, 2022